204 related articles for article (PubMed ID: 28429199)
1. Gastric Bypass and Influence on Improvement of NAFLD.
Alli V; Rogers AM
Curr Gastroenterol Rep; 2017 Jun; 19(6):25. PubMed ID: 28429199
[TBL] [Abstract][Full Text] [Related]
2. Radiographic Improvement of Hepatic Steatosis After Laparoscopic Roux-en-Y Gastric Bypass.
Winder JS; Dudeck BS; Schock S; Lyn-Sue JR; Haluck RS; Rogers AM
Obes Surg; 2017 Feb; 27(2):376-380. PubMed ID: 27440167
[TBL] [Abstract][Full Text] [Related]
3. Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study.
Caiazzo R; Lassailly G; Leteurtre E; Baud G; Verkindt H; Raverdy V; Buob D; Pigeyre M; Mathurin P; Pattou F
Ann Surg; 2014 Nov; 260(5):893-8; discussion 898-9. PubMed ID: 25379859
[TBL] [Abstract][Full Text] [Related]
4. Combined Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Sleeve Gastrectomy or Gastric Bypass?-a Controlled Matched Pair Study of 34 Patients.
Billeter AT; Senft J; Gotthardt D; Knefeli P; Nickel F; Schulte T; Fischer L; Nawroth PP; Büchler MW; Müller-Stich BP
Obes Surg; 2016 Aug; 26(8):1867-74. PubMed ID: 26660688
[TBL] [Abstract][Full Text] [Related]
5. Histologic improvement of NAFLD in patients with obesity after bariatric surgery based on standardized NAS (NAFLD activity score).
von Schönfels W; Beckmann JH; Ahrens M; Hendricks A; Röcken C; Szymczak S; Hampe J; Schafmayer C
Surg Obes Relat Dis; 2018 Oct; 14(10):1607-1616. PubMed ID: 30146425
[TBL] [Abstract][Full Text] [Related]
6. Effect of Roux-en-Y gastric bypass and sleeve gastrectomy on nonalcoholic fatty liver disease: a comparative study.
Froylich D; Corcelles R; Daigle C; Boules M; Brethauer S; Schauer P
Surg Obes Relat Dis; 2016 Jan; 12(1):127-31. PubMed ID: 26077701
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of Laparoscopic Sleeve Gastrectomy and Roux-en-Y Gastric Bypass in Patients Older than 60.
Abbas M; Cumella L; Zhang Y; Choi J; Vemulapalli P; Melvin WS; Camacho D
Obes Surg; 2015 Dec; 25(12):2251-6. PubMed ID: 26001882
[TBL] [Abstract][Full Text] [Related]
8. Influence of Roux-en-Y Gastric Bypass on the Hepatocellular Function and Bile Flow of Obese Patients Assessed by Scintigraphy with DISIDA.
Salgado Júnior W; Donadelli CA; Dos Santos JS; Nonino CB
Obes Surg; 2016 Nov; 26(11):2718-2723. PubMed ID: 27094876
[TBL] [Abstract][Full Text] [Related]
9. Effect of Roux-en-Y gastric bypass on nonalcoholic fatty liver disease evaluated through NAFLD fibrosis score: a prospective study.
Cazzo E; Jimenez LS; Pareja JC; Chaim EA
Obes Surg; 2015 Jun; 25(6):982-5. PubMed ID: 25381118
[TBL] [Abstract][Full Text] [Related]
10. Significant Liver-Related Morbidity After Bariatric Surgery and Its Reversal-a Case Series.
Eilenberg M; Langer FB; Beer A; Trauner M; Prager G; Staufer K
Obes Surg; 2018 Mar; 28(3):812-819. PubMed ID: 28965313
[TBL] [Abstract][Full Text] [Related]
11. Roux-en-Y gastric bypass induces hepatic transcriptomic signatures and plasma metabolite changes indicative of improved cholesterol homeostasis.
Lalloyer F; Mogilenko DA; Verrijken A; Haas JT; Lamazière A; Kouach M; Descat A; Caron S; Vallez E; Derudas B; Gheeraert C; Baugé E; Despres G; Dirinck E; Tailleux A; Dombrowicz D; Van Gaal L; Eeckhoute J; Lefebvre P; Goossens JF; Francque S; Staels B
J Hepatol; 2023 Oct; 79(4):898-909. PubMed ID: 37230231
[TBL] [Abstract][Full Text] [Related]
12. Liver Function in Patients With Nonalcoholic Fatty Liver Disease Randomized to Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy: A Secondary Analysis of a Randomized Clinical Trial.
Kalinowski P; Paluszkiewicz R; Ziarkiewicz-Wróblewska B; Wróblewski T; Remiszewski P; Grodzicki M; Krawczyk M
Ann Surg; 2017 Nov; 266(5):738-745. PubMed ID: 28767558
[TBL] [Abstract][Full Text] [Related]
13. The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: "NASHOST" prospective observational trial.
Praveen Raj P; Gomes RM; Kumar S; Senthilnathan P; Karthikeyan P; Shankar A; Palanivelu C
Surg Obes Relat Dis; 2015; 11(6):1315-22. PubMed ID: 26003897
[TBL] [Abstract][Full Text] [Related]
14. Impact of gastric bypass surgery on the liver fibrosis of patients with extreme obesity and nonalcoholic fatty liver disease in 30-month follow-up.
Norouzian Ostad A; Rajabzadeh F; Jamialahmadi T; Goshayeshi L; Ranjbar G; Rezvani R; Nematy M; Jangjoo A
Updates Surg; 2023 Apr; 75(3):659-669. PubMed ID: 36529770
[TBL] [Abstract][Full Text] [Related]
15. Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease.
Clark JM; Alkhuraishi AR; Solga SF; Alli P; Diehl AM; Magnuson TH
Obes Res; 2005 Jul; 13(7):1180-6. PubMed ID: 16076987
[TBL] [Abstract][Full Text] [Related]
16. Bariatric surgery for non-alcoholic fatty liver disease in individuals with obesity (Base-NAFLD): protocol of a prospective multicenter observational follow-up study.
Wei L; Li M; Zeng N; Liu Y; Bai R; Zhang N; Song J; Zhang P; Yao Q; Yang Z; Zhao X; Zhang Y; Zhang P; Zhang Z
BMC Surg; 2021 Jun; 21(1):298. PubMed ID: 34167531
[TBL] [Abstract][Full Text] [Related]
17. Low-Grade Hepatic Steatosis Is Associated with Long-term Remission of Type 2 Diabetes Independent of Type of Bariatric-Metabolic Surgery.
Lautenbach A; Wernecke M; Mann O; Wagner J; Wolter S; Stoll F; Aberle J
Obes Surg; 2023 Feb; 33(2):530-538. PubMed ID: 36508157
[TBL] [Abstract][Full Text] [Related]
18. Treatment of NASH with Gastric Bypass.
Jirapinyo P; Thompson CC
Curr Gastroenterol Rep; 2018 Sep; 20(10):49. PubMed ID: 30244334
[TBL] [Abstract][Full Text] [Related]
19. Bariatric surgery: An overview.
Aggarwal S; Uniyal M
Natl Med J India; 2014; 27(5):261-6. PubMed ID: 26037426
[No Abstract] [Full Text] [Related]
20. Roux-en-Y Gastric Bypass Surgery on Obstructive Sleep Apnea-Hypopnea Syndrome: Factors Associated with Postoperative Efficacy.
Jiao X; Zou J; Zhang P; Yu H; Di J; Han X; Yin S; Yi H
Obes Surg; 2016 Dec; 26(12):2924-2930. PubMed ID: 27165057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
